Ustekinumab-Aekn is a biologic medication that has been approved by the FDA for the treatment of moderate to severe plaque psoriasis in adults. It works by targeting specific proteins in the body that are involved in the inflammatory response, helping to reduce the symptoms of psoriasis such as redness, itching, and scaling.

This medication is typically administered as an injection under the skin, either by a healthcare provider or self-administered by the patient after proper training. The dosing schedule may vary depending on the individual’s response to treatment and the severity of their condition.

It is important to follow the dosing instructions provided by your healthcare provider and to attend all scheduled appointments for monitoring and evaluation. Ustekinumab-Aekn may take some time to show its full effect, so it is important to be patient and consistent with your treatment.

As with any medication, there are potential side effects to be aware of. Common side effects of ustekinumab-Aekn may include injection site reactions, upper respiratory infections, and headache. It is important to discuss any concerns or side effects with your healthcare provider.

Overall, ustekinumab-Aekn has been shown to be an effective treatment option for individuals with moderate to severe plaque psoriasis. If you have been diagnosed with psoriasis and are considering ustekinumab-Aekn as a treatment option, be sure to discuss it with your healthcare provider to determine if it is the right choice for you.